Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LianBio | 36,300 | reported | 15 Feb 2024 | tx 6+181,500−55,518 |
| HilleVax, Inc. | 25,000 | reported | 19 Aug 2022 | tx 1+25,000 |
| Keenova Therapeutics plc | 0 | reported | 14 Nov 2023 | tx 5+52,553−52,553 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Feb 2024 | TAX_WITHHOLDING | LianBio | 19,218 | 4.76 USD | |
| 15 Feb 2024 | EXERCISE | LianBio | 36,300 | 2.52 USD | |
| 15 Feb 2024 | EXERCISE | LianBio | 36,300 | 0.00 USD | deriv |
| 14 Nov 2023 | OTHER | Keenova Therapeutics plc | 23,122 | 0.00 USD | |
| 16 Jun 2023 | TAX_WITHHOLDING | Keenova Therapeutics plc | 3,154 | 1.28 USD | |
| 16 Jun 2023 | OTHER | Keenova Therapeutics plc | 26,277 | — | |
| 21 Jun 2023 | GRANT_AWARD | LianBio | 36,300 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Keenova Therapeutics plc | 26,277 | 0.00 USD | |
| 11 Oct 2022 | GRANT_AWARD | Keenova Therapeutics plc | 26,276 | 0.00 USD | deriv |
| 19 Aug 2022 | GRANT_AWARD | HilleVax, Inc. | 25,000 | 0.00 USD | deriv |
| 23 Jun 2022 | GRANT_AWARD | LianBio | 36,300 | 0.00 USD | deriv |
| 31 Oct 2021 | GRANT_AWARD | LianBio | 72,600 | 0.00 USD | deriv |